# Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia

> **NCT06890897** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 174 (estimated)

## Conditions studied

- Zoster; Herpes, Trigeminal Neuralgia (Etiology)

## Interventions

- **DRUG:** Esketamine group
- **DRUG:** PRF group

## Key facts

- **NCT ID:** NCT06890897
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06890897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06890897, "Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06890897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*